|
|
Study on the Influencing Factors of Cervical Lymph Node Metastasis in Papillary Thyroid Microcarcinoma |
JI Tian-long |
Department of Radiotherapy, the First Affiliated Hospital of China Medical University, Shenyang 100001, China |
|
|
Abstract Objective: To investigate the influencing factors of the cervical lymph node metastasis in papillary thyroid microcarcinoma (PTMC) and to provide a theoretical basis for cervical lymph node dissection. Methods: A total of 80 PTMC patients treated in the Department of Breast and Thyroid Surgery of our Hospital from January 2017 to January 2018 were selected in the study. All the patients accepted the first surgical treatment and were confirmed by pathology. The clinical data of all PTMC patients were retrospectively analyzed, and the related factors such as gender, age, number of primary lesions, tumor diameter and extrathyroidal invasions were analyzed. The factors that actually affected the lymph node metastasis of PTMC patients were explored. Results: All patients underwent prophylactic central lymph node dissection. Lymph node metastasis occurred in 26 patients in the central region and in 13 patients in the lateral neck region. The rate of lymph node metastasis in the central region of men was 41.18%, and the rate of lymph node metastasis in the lateral neck region was 23.53%, which were significantly higher than that of women's 30.16% and 14.29%. The differences were statistically significant (P<0.05). The regional metastasis rate of the patients of ≤45 years was 45.83%, and the lateral neck region metastasis rate was 20.83%, which were significantly higher than those of patients >45 years old (12.50%, 9.38%) and the differences were statistically significant (P<0.05). The lymph node metastasis rate in the central region and in the lateral neck region of tumor diameter <0.5 cm were 27.27% and 9.09% respectively, which were significantly lower than those of the tumor diameter 0.5-1.0 cm (38.89%, 25.00%) (P<0.05). The rate of lymph node metastasis in the central region of single focus was 20.37%, which was significantly lower than that of 57.69% in the multifocal lesions; the rate of lymph node metastasis in the cervical region of the single lesion was 11.11%, which was significantly lower than 26.92% in the multifocal area; the differences were statistically significant (P<0.05). The metastasis rate of the patients with extrathyroidal invasions in the central area was 60.00%, which is significantly higher than that without extrathyroidal invasions (30.67%). About the tumor neck invasion of the lateral neck region, the lymph node metastasis rate of the patients with extrathyroidal invasions was 40.00%, which was significantly higher than that without extrathyroidal invasions(14.67%). The differences were statistically significant (P<0.05). Logistic regression analysis showed that gender and tumor size were independent influencing factors of lymph node metastasis in the central and lateral neck regions (P<0.05). Conclusion: Young, male, multifocal, tumor diameter 0.5-1.0 cm and extrathyroidal invasions are risk factors for cervical lymph node metastasis in patients with PTMC. Gender and tumor size are independent factors affecting central/lateral cervical lymph node metastasis in PTMC patients.
|
Received: 15 September 2018
|
Corresponding Authors:
JI Tian-long. E-mail: 18040095029@163.com
|
|
|
|
[1] Chinese Anti-Cancer Association Committee on Thyroid Cancer. Chinese expert consensus on diagnosis and treatment of papillary thyroid cancer (2016 Edition)[J]. Chin J Clin Oncol, 2016,43(10): 405-411. [2] Glattre E, Kravdal O.Male and female parity and risk of thyroid cancer[J]. Int J Cancer, 1994, 58(4): 616-617. [3] Gimm O, Rath FW, Dralle H.Pattern of lymph node metastases in papillary thyroid carcinoma[J]. Br J Surg, 1998,85(2): 252-254. [4] Ma XK, Huang JK, Peng DF, et al.Clinical characteristics of papillary thyroid microcarcinoma and risk factors for cervical lymph node metastasis: a clinical analysis of 228 cases[J]. China Oncology, 2019,29(8): 590-594. [5] Sosa JA, Bowman HM, Tielsch JM, et al.The importance of surgeon experience for clinical and economic outcomes from thyroidectomy[J]. Ann Surg, 1998,228(3): 320-330. [6] Ren L.Influence factors and operation cleaning scope of cervical lymphnode metastasis on papillary thyroid micro carcinoma [D]. Southwest Medical University, 2016. [7] Zhang J, Wang YT, Xu B, et al.Correlation between sonographic features of primary papillary thyroid microcarcinoma and cervical lymph node metastasis[J]. Chinese Journal of Medical Imaging, 2016,24(8): 573-577, 579. [8] Chen L, Wu M, Li WS, et al.Analysis of influencing factors of cervical lymph node metastasis in patients with thyroid micropapillary carcinoma[J]. Shandong Medical Journal, 2018,58(31): 75-77. [9] Ma XK, Huang JK, Peng DF, et al.Clinical characteristics of papillary thyroid microcarcinoma and risk factors for cervical lymph node metastasis: a clinical analysis of 228 cases[J]. China Oncology, 2019,29(8): 590-594. [10] Wang XQ, Wei X, Xu Y, et al.Analysis of the relationship between ultrasonographic features and cervical lymph node skip metastasis of papillary thyroid micro-carcinoma[J]. Zhonghua Zhong Liu Za Zhi, 2019,41(5): 373-377. [11] Wang Y, Guan Q, Xiang J.Nomogram for predicting central lymph node metastasis in papillary thyroid microcarcinoma: A retrospective cohort study of 8668 patients[J]. Int J Surg, 2018,55:98-102. [12] Guo M, Yang HJ, Zhang JF, et al.Clinicopathological analysis of 84 cases of thyroid micropapillary carcinoma[J]. Chinese Journal of Oncology Prevention and Treatment, 2011, 3(4): 69-71. [13] Zhang D, Gao L, Xie L, et al.Comparison between video-assisted and open lateral neck dissection for papillary thyroid carcinoma with lateral neck lymph node metastasis: a prospective randomized study[J]. J Laparoendosc Adv Surg Tech A, 2017,27(11): 1151-1157. [14] Tastekin E, Can N, Ayturk S, et al.Clinically undetectable occult thyroid papillary carcinoma presenting with cervical lymph node metastasis[J]. Acta Endocrinol (Buchar), 2016,12(1): 72-76. [15] Zhang D, Xie L, He G, et al.A comparative study of the surgical outcomes between video-assisted and open lateral neck dissection for papillary thyroid carcinoma with lateral neck lymph node metastases[J]. Am J Otolaryngol, 2017,38(2): 115-120. [16] Bian XY, Sun SS, Guo WY, et al.Risk factor analysis for cervical nodal metastasis in papillary microcarcinoma[J]. Chinese Journal of Clinical Oncology, 2015(13): 28-32. [17] Sessa L, Lombardi CP, De Crea C, et al.Risk factors for central neck lymph node metastases in micro-versus macro-clinically node negative papillary thyroid carcinoma[J]. World J Surg, 2018,42(3): 623-629. [18] Wang JB, Sun YY, Shi LH, et al.Predictive factors for non-small-volume central lymph node metastases (more than 5 or ≥ 2 mm) in clinically node-negative papillary thyroid carcinoma[J]. Medicine (Baltimore), 2019,98(1): e14028. [19] Bian XH, Li SJ, Zhang G, et al.Effective factors of cervical lymph node metastasis of papillary thyroid microcarcinoma (1180 cases)[J]. International Journal of Surgery, 2013,40(2): 105-108. [20] Shen WL, LV J, Hei H, et al.Analysis of risk factors for lateral neck lymph node metastasis in cN0 papillary thyroid microcarcinoma[J]. Chin J Gen Surg, 2019,28(5): 39-45. [21] Ma WQ, Zhou P, Liang YP, et al.Preliminary construction of risk scoring system for estimation of central cervical lymph node metastasis in papillary thyroid microcarcinoma[J]. Chin J Gen Surg, 2018,27(6): 90-98. [22] Zhai BW, Gao QJ, Zhao DW.Analysis of risk factors for cervical lymph node metastases in papillary thyroid microcarcinoma[J]. Chin J Gen Surg, 2016, 25(11): 1573-1579. |
[1] |
Li Baoming, Hu Jiarui, Xu Haijun, Wang Cong, Jiang Yanni, Zhang Zhihong, Xu Jun. Deep Cascaded Network for Automated Detection of Cancer MetastasisRegion from Whole Slide Image of Breast Lymph Node[J]. Chinese Journal of Biomedical Engineering, 2020, 39(3): 257-264. |
[2] |
Xu Jie, Wang Xunheng, Li Lihua. Investigating Brain Networks for ADHD Children Based on Phase Synchronization of Resting State fMRI[J]. Chinese Journal of Biomedical Engineering, 2020, 39(3): 265-270. |
|
|
|
|